Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 4 March 1983:
Vol. 219. no. 4588, pp. 1032 - 1037
DOI: 10.1126/science.6823565

Articles

Science, Vol 219, Issue 4588, 1032-1037
Copyright © 1983 by American Association for the Advancement of Science


articles

Implication of nonlinear kinetics on risk estimation in carcinogenesis

DG Hoel, NL Kaplan, and MW Anderson

Efforts in estimating carcinogenic risk in humans from long-term exposure to chemical carcinogens have centered on the problem of low-dose extrapolation. For chemicals with metabolites that interact with DNA, it may be more meaningful to relate tumor response to the concentration of the DNA adducts in the target organ rather than to the applied dose. Many data suggest that the relation between tumor response and concentration of DNA adducts in the target organ may be linear. This implies that the nonlinearities of the dose-response curve for tumor induction may be due to the kinetic processes involved in the formation of carcinogen metabolite--DNA adducts. Of particular importance is the possibility that the kinetic processes may show a nonlinear "hockey-stick" like behavior which results from saturation of detoxification or DNA repair processes. The mathematical models typically used for low-dose extrapolation are shown potentially to overestimate risk by several orders of magnitude when nonlinear kinetics are present.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Air samples versus biomarkers for epidemiology.
Y S Lin, L L Kupper, and S M Rappaport (2005)
Occup. Environ. Med. 62, 750-760
   Abstract »    Full Text »    PDF »
Response to the reports of Andersen, Bogen and Downs.
D. G Hoel (1998)
Human and Experimental Toxicology 17, 703-704
   PDF »
Effects of variation in detoxification rate on dose monitoring through adducts.
U. Fost, M. Tornqvist, M. Leutbecher, F. Granath, E. Hallier, and L. Ehrenberg (1995)
Human and Experimental Toxicology 14, 201-203
   Abstract »    PDF »
Response.
F. P. PERERA, D. P. RALL, and I. B. WEINSTEIN (1991)
Science 252, 903-904
   PDF »
Carcinogens and human health: Part 1.
F. Perera (1990)
Science 250, 1644-1646
   PDF »
Utilization of the Quantitative Component of the Information Obtained from Short Term Tests.
S. Parodi, P. Boero, M. Taningher, P. Storace, and L. Santi (1987)
Toxicol Pathol 15, 206-212
   Abstract »    PDF »
Detection of smoking-related covalent DNA adducts in human placenta.
R. Everson, E Randerath, R. Santella, R. Cefalo, T. Avitts, and K Randerath (1986)
Science 231, 54-57
   Abstract »    PDF »
The Setting of Particulate Exposure Levels for Chronic Inhalation Toxicity Studies.
P. E. Morrow (1986)
International Journal of Toxicology 5, 533-544
   Abstract »    PDF »
Dose Relationships in Experimental Carcinogenesis: Dependence on Multiple Factors Including Biotransformation.
D. B. Clayson (1985)
Toxicol Pathol 13, 119-127
   Abstract »    PDF »
A Selected Review of Risk Models: One Hit, Multihit, Multistage, Probit, Weibull, and Pharmacokinetic.
B. Hanes and T. Wedel (1985)
International Journal of Toxicology 4, 271-278
   Abstract »    PDF »
Criteria for evidence of chemical carcinogenicity. Interdisciplinary Panel on Carcinogenicity.
(1984)
Science 225, 682-687
   Abstract »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)